{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:07:02Z","timestamp":1794330422879,"version":"4.9.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41577-025-01255-1","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:02:04Z","timestamp":1767949324000},"page":"410-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Inflame and restrain \u2014 the paradoxical roles of IL-12 and IL-23 in immunity"],"prefix":"10.1038","volume":"26","author":[{"given":"Lukas","family":"Rindlisbacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria N.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1541-7867","authenticated-orcid":false,"given":"Burkhard","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"1255_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.170.3.827","volume":"170","author":"M Kobayashi","year":"1989","unstructured":"Kobayashi, M. et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827\u2013845 (1989).","journal-title":"J. Exp. Med."},{"key":"1255_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1126\/science.8097338","volume":"260","author":"CS Hsieh","year":"1993","unstructured":"Hsieh, C. S. et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547\u2013549 (1993).","journal-title":"Science"},{"key":"1255_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133\u2013146 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"1255_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","volume":"50","author":"EDT Wojno","year":"2019","unstructured":"Wojno, E. D. T., Hunter, C. A. & Stumhofer, J. S. The immunobiology of the Iinterleukin-12 family: room for discovery. Immunity 50, 851\u2013870 (2019).","journal-title":"Immunity"},{"key":"1255_CR5","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.4049\/jimmunol.151.5.2444","volume":"151","author":"PT Mehrotra","year":"1993","unstructured":"Mehrotra, P. T., Wu, D., Crim, J. A., Mostowski, H. S. & Siegel, J. P. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J. Immunol. 151, 2444\u20132452 (1993).","journal-title":"J. Immunol."},{"key":"1255_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI118843","volume":"98","author":"N Bhardwaj","year":"1996","unstructured":"Bhardwaj, N., Seder, R. A., Reddy, A. & Feldman, M. V. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. J. Clin. Invest. 98, 715\u2013722 (1996).","journal-title":"J. Clin. Invest."},{"key":"1255_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715\u2013725 (2000).","journal-title":"Immunity"},{"key":"1255_CR8","doi-asserted-by":"publisher","first-page":"1331217","DOI":"10.3389\/fimmu.2024.1331217","volume":"15","author":"JG Krueger","year":"2024","unstructured":"Krueger, J. G. et al. IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy. Front. Immunol. 15, 1331217 (2024).","journal-title":"Front. Immunol."},{"key":"1255_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DAA Vignali","year":"2012","unstructured":"Vignali, D. A. A. & Kuchroo, V. K. IL-12 family cytokines: immunological playmakers. Nat. Immunol. 13, 722\u2013728 (2012).","journal-title":"Nat. Immunol."},{"key":"1255_CR10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41590-021-01009-w","volume":"22","author":"S Tuzlak","year":"2021","unstructured":"Tuzlak, S. et al. Repositioning TH cell polarization from single cytokines to complex help. Nat. Immunol. 22, 1210\u20131217 (2021). This opinion piece argues that classifying T helper cells by the immune cells they assist \u2014 rather than by single cytokines \u2014 better reflects their functional diversity, plasticity and in vivo relevance.","journal-title":"Nat. Immunol."},{"key":"1255_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni0909-929","volume":"10","author":"A O\u2019Garra","year":"2009","unstructured":"O\u2019Garra, A. & Murphy, K. M. From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce TH1 development. Nat. Immunol. 10, 929\u2013932 (2009).","journal-title":"Nat. Immunol."},{"key":"1255_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/cdd.2014.134","volume":"22","author":"S Tugues","year":"2015","unstructured":"Tugues, S. et al. New insights into IL-12-mediated tumor suppression. Cell Death Differ. 22, 237\u2013246 (2015).","journal-title":"Cell Death Differ."},{"key":"1255_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai, T., Ikegawa, M., Ori, D. & Akira, S. Decoding Toll-like receptors: recent insights and perspectives in innate immunity. Immunity 57, 649\u2013673 (2024).","journal-title":"Immunity"},{"key":"1255_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1084\/jem.185.5.825","volume":"185","author":"L Rogge","year":"1997","unstructured":"Rogge, L. et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185, 825\u2013832 (1997).","journal-title":"J. Exp. Med."},{"key":"1255_CR15","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.4049\/jimmunol.162.7.3926","volume":"162","author":"L Rogge","year":"1999","unstructured":"Rogge, L. et al. Antibodies to the IL-12 receptor \u03b22 chain mark human Th1 but not Th2 cells in vitro and in vivo. J. Immunol. 162, 3926\u20133932 (1999).","journal-title":"J. Immunol."},{"key":"1255_CR16","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1073\/pnas.92.16.7307","volume":"92","author":"CM Bacon","year":"1995","unstructured":"Bacon, C. M. et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl Acad. Sci. USA 92, 7307\u20137311 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1255_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","volume":"100","author":"SJ Szabo","year":"2000","unstructured":"Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655\u2013669 (2000).","journal-title":"Cell"},{"key":"1255_CR18","doi-asserted-by":"publisher","first-page":"15137","DOI":"10.1073\/pnas.261570598","volume":"98","author":"AA Lighvani","year":"2001","unstructured":"Lighvani, A. A. et al. T-bet is rapidly induced by interferon-\u03b3 in lymphoid and myeloid cells. Proc. Natl Acad. Sci. USA 98, 15137\u201315142 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1255_CR19","doi-asserted-by":"publisher","first-page":"e01035","DOI":"10.1128\/IAI.01035-16","volume":"85","author":"A Villegas-Mendez","year":"2017","unstructured":"Villegas-Mendez, A. et al. Gamma interferon mediates experimental cerebral malaria by signaling within both the hematopoietic and nonhematopoietic compartments. Infect. Immun. 85, e01035\u201316 (2017).","journal-title":"Infect. Immun."},{"key":"1255_CR20","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1084\/jem.158.3.670","volume":"158","author":"CF Nathan","year":"1983","unstructured":"Nathan, C. F., Murray, H. W., Wiebe, M. E. & Rubin, B. Y. Identification of interferon-\u03b3 as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670\u2013689 (1983).","journal-title":"J. Exp. Med."},{"key":"1255_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm, U., Klamp, T., Groot, M. & Howard, J. C. Cellular responses to interferon-\u03b3. Annu. Rev. Immunol. 15, 749\u2013795 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"1255_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jlb.59.4.505","volume":"59","author":"G Trinchieri","year":"1996","unstructured":"Trinchieri, G. & Gerosa, F. Immunoregulation by interleukin-12. J. Leukoc. Biol. 59, 505\u2013511 (1996).","journal-title":"J. Leukoc. Biol."},{"key":"1255_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(87)92863-7","volume":"1","author":"HS Panitch","year":"1987","unstructured":"Panitch, H. S., Haley, A. S., Hirsch, R. L. & Johnson, K. P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1, 893\u2013895 (1987).","journal-title":"Lancet"},{"key":"1255_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4049\/jimmunol.155.10.5011","volume":"155","author":"A Khoruts","year":"1995","unstructured":"Khoruts, A., Miller, S. D. & Jenkins, M. K. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Thl cells. J. Immunol. 155, 501\u2013502 (1995).","journal-title":"J. Immunol."},{"key":"1255_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/1074-7613(95)90169-8","volume":"3","author":"LB Nicholson","year":"1995","unstructured":"Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B. & Kuchroo, V. K. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3, 397\u2013405 (1995).","journal-title":"Immunity"},{"key":"1255_CR26","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","volume":"158","author":"K Vermeire","year":"1997","unstructured":"Vermeire, K. et al. Accelerated collagen-induced arthritis in IFN-\u03b3 receptor-deficient mice. J. Immunol. 158, 5507\u20135513 (1997).","journal-title":"J. Immunol."},{"key":"1255_CR27","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.4049\/jimmunol.158.12.5997","volume":"158","author":"LS Jones","year":"1997","unstructured":"Jones, L. S. et al. IFN-\u03b3-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158, 5997\u20136005 (1997).","journal-title":"J. Immunol."},{"key":"1255_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.192.1.123","volume":"192","author":"CQ Chu","year":"2000","unstructured":"Chu, C. Q., Wittmer, S. & Dalton, D. K. Failure to suppress the expansion of the activated CD4 T cell population in interferon \u03b3-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123\u2013128 (2000).","journal-title":"J. Exp. Med."},{"key":"1255_CR29","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1084\/jem.185.12.2177","volume":"185","author":"K Frei","year":"1997","unstructured":"Frei, K. et al. Tumor necrosis factor \u03b1 and lymphotoxin \u03b1 are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 2177 (1997).","journal-title":"J. Exp. Med."},{"key":"1255_CR30","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1084\/jem.187.9.1517","volume":"187","author":"DS Riminton","year":"1998","unstructured":"Riminton, D. S. et al. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187, 1517\u20131528 (1998).","journal-title":"J. Exp. Med."},{"key":"1255_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.immunol.16.1.495","volume":"16","author":"MK Gately","year":"1998","unstructured":"Gately, M. K. et al. The interleukin-12\/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495\u2013521 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"1255_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1084\/jem.187.4.537","volume":"187","author":"BM Segal","year":"1998","unstructured":"Segal, B. M., Dwyer, B. K. & Shevach, E. M. An interleukin (IL)-10\/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187, 537\u2013546 (1998).","journal-title":"J. Exp. Med."},{"key":"1255_CR33","first-page":"249","volume":"21","author":"EM Shevach","year":"1999","unstructured":"Shevach, E. M., Chang, J. T. & Segal, B. M. The critical role of IL-12 and the IL-12R\u03b2 2 subunit in the generation of pathogenic autoreactive Th1 cells. Springer Semin. Immunopathol. 21, 249\u2013262 (1999).","journal-title":"Springer Semin. Immunopathol."},{"key":"1255_CR34","doi-asserted-by":"publisher","first-page":"7899","DOI":"10.1074\/jbc.M008262200","volume":"276","author":"K Pahan","year":"2001","unstructured":"Pahan, K. et al. Induction of nitric-oxide synthase and activation of NF-kB by interleukin-12 p40 in microglial cells. J. Biol. Chem. 276, 7899\u20137905 (2001).","journal-title":"J. Biol. Chem."},{"key":"1255_CR35","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","volume":"168","author":"C Parham","year":"2002","unstructured":"Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 Is composed of IL-12R\u03b21 and a novel cytokine receptor subunit, IL-23R1. J. Immunol. 168, 5699\u20135708 (2002).","journal-title":"J. Immunol."},{"key":"1255_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI0215751","volume":"110","author":"B Becher","year":"2002","unstructured":"Becher, B., Durell, B. G. & Noelle, R. J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110, 493\u2013497 (2002).","journal-title":"J. Clin. Invest."},{"key":"1255_CR37","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744\u2013748 (2003).","journal-title":"Nature"},{"key":"1255_CR38","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.4049\/jimmunol.169.12.7104","volume":"169","author":"B Gran","year":"2002","unstructured":"Gran, B. et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169, 7104\u20137110 (2002). Together with Becher et al. (2002) and Cua et al. (2003), this study shows that IL-23 and not IL-12 is required for the development of EAE.","journal-title":"J. Immunol."},{"key":"1255_CR39","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal, S., Ghilardi, N., Xie, M. H., De Sauvage, F. J. & Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910\u20131914 (2003).","journal-title":"J. Biol. Chem."},{"key":"1255_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","volume":"126","author":"MM Curtis","year":"2009","unstructured":"Curtis, M. M. & Way, S. S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126, 177\u2013185 (2009).","journal-title":"Immunology"},{"key":"1255_CR41","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1084\/jem.20071450","volume":"205","author":"F Gerosa","year":"2008","unstructured":"Gerosa, F. et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205, 1447\u20131461 (2008).","journal-title":"J. Exp. Med."},{"key":"1255_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123\u20131132 (2005).","journal-title":"Nat. Immunol."},{"key":"1255_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","volume":"202","author":"CL Langrish","year":"2004","unstructured":"Langrish, C. L. et al. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202, 96\u2013105 (2004).","journal-title":"Immunol. Rev."},{"key":"1255_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbrc.2009.05.140","volume":"386","author":"N Morishima","year":"2009","unstructured":"Morishima, N., Mizoguchi, I., Takeda, K., Mizuguchi, J. & Yoshimoto, T. TGF-\u03b2 is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochem. Biophys. Res. Commun. 386, 105\u2013110 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1255_CR45","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.4049\/jimmunol.0902796","volume":"184","author":"L Riol-Blanco","year":"2010","unstructured":"Riol-Blanco, L. et al. IL-23 receptor regulates unconventional IL-17-producing T cells that control infection. J. Immunol. 184, 1710 (2010).","journal-title":"J. Immunol."},{"key":"1255_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485\u2013517 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"1255_CR47","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","volume":"168","author":"C Parham","year":"2002","unstructured":"Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R\u03b21 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699\u20135708 (2002).","journal-title":"J. Immunol."},{"key":"1255_CR48","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov, I. I. et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121\u20131133 (2006).","journal-title":"Cell"},{"key":"1255_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan, P. R. et al. Transforming growth factor-\u03b2 induces development of the TH17 lineage. Nature 441, 231\u2013234 (2006).","journal-title":"Nature"},{"key":"1255_CR50","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967\u2013974 (2007).","journal-title":"Nat. Immunol."},{"key":"1255_CR51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.1993","volume":"12","author":"K Hirota","year":"2011","unstructured":"Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255\u2013263 (2011).","journal-title":"Nat. Immunol."},{"key":"1255_CR52","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.immuni.2024.09.017","volume":"57","author":"D Mangani","year":"2024","unstructured":"Mangani, D. et al. Transcription factor TCF1 binds to ROR\u03b3t and orchestrates a regulatory network that determines homeostatic Th17 cell state. Immunity 57, 2565\u20132582.e6 (2024).","journal-title":"Immunity"},{"key":"1255_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.immuni.2015.11.009","volume":"44","author":"R Jain","year":"2016","unstructured":"Jain, R. et al. Interleukin-23-induced transcription factor blimp-1 promotes pathogenicity of T helper 17 cells. Immunity 44, 131\u2013142 (2016).","journal-title":"Immunity"},{"key":"1255_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08404-w","volume":"10","author":"K Yasuda","year":"2019","unstructured":"Yasuda, K. et al. Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation. Nat. Commun. 10, 549 (2019).","journal-title":"Nat. Commun."},{"key":"1255_CR55","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3390\/cells9092044","volume":"9","author":"G Pastor-Fern\u00e1ndez","year":"2020","unstructured":"Pastor-Fern\u00e1ndez, G., Mariblanca, I. R. & Navarro, M. N. Decoding IL-23 signaling cascade for new therapeutic opportunities. Cells 9, 2044 (2020).","journal-title":"Cells"},{"key":"1255_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-065X.2008.00699.x","volume":"226","author":"Y Iwakura","year":"2008","unstructured":"Iwakura, Y., Nakae, S., Saijo, S. & Ishigame, H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226, 57\u201379 (2008).","journal-title":"Immunol. Rev."},{"key":"1255_CR57","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1084\/jem.20030896","volume":"198","author":"CA Murphy","year":"2003","unstructured":"Murphy, C. A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951\u20131957 (2003).","journal-title":"J. Exp. Med."},{"key":"1255_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233\u2013240 (2005). This is the first report that IL-23 stimulates IL-17 production in T cells.","journal-title":"J. Exp. Med."},{"key":"1255_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","volume":"24","author":"A Schnell","year":"2023","unstructured":"Schnell, A., Littman, D. R. & Kuchroo, V. K. TH17 cell heterogeneity and its role in tissue inflammation. Nat. Immunol. 24, 19\u201329 (2023).","journal-title":"Nat. Immunol."},{"key":"1255_CR60","first-page":"61","volume":"119","author":"S Haak","year":"2009","unstructured":"Haak, S. et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119, 61\u201369 (2009).","journal-title":"J. Clin. Invest."},{"key":"1255_CR61","doi-asserted-by":"publisher","first-page":"eaaz6563","DOI":"10.1126\/sciimmunol.aaz6563","volume":"6","author":"T Regen","year":"2021","unstructured":"Regen, T. et al. IL-17 controls central nervous system autoimmunity through the intestinal microbiome. Sci. Immunol. 6, eaaz6563 (2021).","journal-title":"Sci. Immunol."},{"key":"1255_CR62","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/ni.1698","volume":"10","author":"MJ McGeachy","year":"2009","unstructured":"McGeachy, M. J. et al. Interleukin 23 receptor is essential for terminal differentiation of effector T helper type 17 cells in vivo. Nat. Immunol. 10, 314 (2009).","journal-title":"Nat. Immunol."},{"key":"1255_CR63","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/ni.2027","volume":"12","author":"L Codarri","year":"2011","unstructured":"Codarri, L. et al. ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560\u2013567 (2011). This report demonstrates that IL-23 stimulates GM-CSF production in T cells, which enables their encephalitogenic programme.","journal-title":"Nat. Immunol."},{"key":"1255_CR64","doi-asserted-by":"publisher","first-page":"eadd6137","DOI":"10.1126\/scitranslmed.add6137","volume":"15","author":"HJ Paust","year":"2023","unstructured":"Paust, H. J. et al. CD4+ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12. Sci. Transl. Med. 15, eadd6137 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1255_CR65","doi-asserted-by":"publisher","first-page":"eadg3517","DOI":"10.1126\/sciimmunol.adg3517","volume":"8","author":"AJ Forde","year":"2023","unstructured":"Forde, A. J. et al. Metabolic rewiring tunes dermal macrophages in staphylococcal skin infection. Sci. Immunol. 8, eadg3517 (2023).","journal-title":"Sci. Immunol."},{"key":"1255_CR66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2017.01.007","volume":"46","author":"S Spath","year":"2017","unstructured":"Spath, S. et al. Dysregulation of the cytokine GM-CSF induces spontaneous phagocyte invasion and immunopathology in the central nervous system. Immunity 46, 245\u2013260 (2017).","journal-title":"Immunity"},{"key":"1255_CR67","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41590-021-01117-7","volume":"23","author":"A Amorim","year":"2022","unstructured":"Amorim, A. et al. IFN\u03b3 and GM-CSF control complementary differentiation programs in the monocyte-to-phagocyte transition during neuroinflammation. Nat. Immunol. 23, 217\u2013228 (2022).","journal-title":"Nat. Immunol."},{"key":"1255_CR68","doi-asserted-by":"publisher","first-page":"eaat8410","DOI":"10.1126\/scitranslmed.aat8410","volume":"10","author":"S Tugues","year":"2018","unstructured":"Tugues, S. et al. Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells. Sci. Transl. Med. 10, eaat8410 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1255_CR69","doi-asserted-by":"publisher","first-page":"101518","DOI":"10.1016\/j.smim.2021.101518","volume":"54","author":"F Ingelfinger","year":"2021","unstructured":"Ingelfinger, F., De Feo, D. & Becher, B. GM-CSF: master regulator of the T cell\u2013phagocyte interface during inflammation. Semin. Immunol. 54, 101518 (2021).","journal-title":"Semin. Immunol."},{"key":"1255_CR70","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1172\/JCI118946","volume":"98","author":"B Becher","year":"1996","unstructured":"Becher, B., Dodelet, V., Fedorowicz, V. & Antel, J. P. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98, 1539\u20131543 (1996).","journal-title":"J. Clin. Invest."},{"key":"1255_CR71","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1471-4159.2005.03368.x","volume":"95","author":"CS Constantinescu","year":"2005","unstructured":"Constantinescu, C. S. et al. Astrocytes as antigen-presenting cells: expression of IL-12\/IL-23. J. Neurochem. 95, 331\u2013340 (2005).","journal-title":"J. Neurochem."},{"key":"1255_CR72","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/nm.2965","volume":"18","author":"J Vom Berg","year":"2012","unstructured":"Vom Berg, J. et al. Inhibition of IL-12\/IL-23 signaling reduces Alzheimer\u2019s disease-like pathology and cognitive decline. Nat. Med. 18, 1812\u20131819 (2012).","journal-title":"Nat. Med."},{"key":"1255_CR73","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s43587-025-00816-2","volume":"5","author":"S Schneeberger","year":"2025","unstructured":"Schneeberger, S. et al. Interleukin-12 signaling drives Alzheimer\u2019s disease pathology through disrupting neuronal and oligodendrocyte homeostasis. Nat. Aging 5, 622\u2013641 (2025). This report shows that IL-12 can enhance Alzheimer\u2019s disease pathology.","journal-title":"Nat. Aging"},{"key":"1255_CR74","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner, F. L., Ransohoff, R. M. & Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358\u2013372 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"1255_CR75","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41593-023-01435-z","volume":"26","author":"M Andreadou","year":"2023","unstructured":"Andreadou, M. et al. IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice. Nat. Neurosci. 26, 1701\u20131712 (2023). This report shows that IL-12R signaling in neurons can be neuroprotective in EAE.","journal-title":"Nat. Neurosci."},{"key":"1255_CR76","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/imm.12214","volume":"141","author":"M Jana","year":"2014","unstructured":"Jana, M., Mondal, S., Jana, A. & Pahan, K. Interleukin-12 (IL-12), but not IL-23, induces the expression of IL-7 in microglia and macrophages: implications for multiple sclerosis. Immunology 141, 549\u2013563 (2014).","journal-title":"Immunology"},{"key":"1255_CR77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuron.2020.01.004","volume":"106","author":"MH Wertz","year":"2020","unstructured":"Wertz, M. H. et al. Genome-wide in vivo CNS screening identifies genes that modify CNS neuronal survival and mHTT toxicity. Neuron 106, 76\u201389.e8 (2020).","journal-title":"Neuron"},{"key":"1255_CR78","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W. H. & Sch\u00f6n, M. P. Psoriasis. Lancet 386, 983\u2013994 (2015).","journal-title":"Lancet"},{"key":"1255_CR79","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M. A., Su\u00e1rez-Fari\u00f1as, M. & Krueger, J. G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227\u2013255 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"1255_CR80","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","volume":"113","author":"LM Austin","year":"1999","unstructured":"Austin, L. M., Ozawa, M., Kikuchi, T., Walters, I. B. & Krueger, J. G. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-\u03b3, interleukin-2, and tumor necrosis factor-\u03b1, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J. Invest. Dermatol. 113, 752\u2013759 (1999).","journal-title":"J. Invest. Dermatol."},{"key":"1255_CR81","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","volume":"25","author":"W Lew","year":"2004","unstructured":"Lew, W., Bowcock, A. M. & Krueger, J. G. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \u2018type 1\u2019 inflammatory gene expression. Trends Immunol. 25, 295\u2013305 (2004).","journal-title":"Trends Immunol."},{"key":"1255_CR82","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1172\/JCI117308","volume":"94","author":"FO Nestle","year":"1994","unstructured":"Nestle, F. O., Turka, L. A. & Nickoloff, B. J. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J. Clin. Invest. 94, 202\u2013209 (1994).","journal-title":"J. Clin. Invest."},{"key":"1255_CR83","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","volume":"102","author":"JF Schlaak","year":"1994","unstructured":"Schlaak, J. F. et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J. Invest. Dermatol. 102, 145\u2013149 (1994).","journal-title":"J. Invest. Dermatol."},{"key":"1255_CR84","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1046\/j.1523-1747.1998.00446.x","volume":"111","author":"N Yawalkar","year":"1998","unstructured":"Yawalkar, N., Karlen, S., Hunger, R., Brand, C. U. & Braathen, L. R. Expression of interleukin-12 is increased in psoriatic skin. J. Invest. Dermatol. 111, 1053\u20131057 (1998).","journal-title":"J. Invest. Dermatol."},{"key":"1255_CR85","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/bjd.13469","volume":"172","author":"RG Langley","year":"2015","unstructured":"Langley, R. G. et al. Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up. Br. J. Dermatol. 172, 1371\u20131383 (2015).","journal-title":"Br. J. Dermatol."},{"key":"1255_CR86","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","volume":"35","author":"Y Cai","year":"2011","unstructured":"Cai, Y. et al. Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation. Immunity 35, 596\u2013610 (2011).","journal-title":"Immunity"},{"key":"1255_CR87","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1172\/JCI61862","volume":"122","author":"S Pantelyushin","year":"2012","unstructured":"Pantelyushin, S. et al. Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122, 2252\u20132256 (2012).","journal-title":"J. Clin. Invest."},{"key":"1255_CR88","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1056\/NEJMoa1501646","volume":"373","author":"KB Gordon","year":"2015","unstructured":"Gordon, K. B. et al. A phase 2 trial of guselkumab versus adalimumab for plaque psoriasis. N. Engl. J. Med. 373, 136\u2013144 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1255_CR89","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","volume":"376","author":"KA Papp","year":"2017","unstructured":"Papp, K. A. et al. Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis. N. Engl. J. Med. 376, 1551\u20131560 (2017). This clinical trial suggests that IL-12 has protective properties in psoriasis.","journal-title":"N. Engl. J. Med."},{"key":"1255_CR90","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jaad.2016.11.042","volume":"76","author":"K Reich","year":"2017","unstructured":"Reich, K. et al. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial. J. Am. Acad. Dermatol. 76, 418\u2013431 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"1255_CR91","doi-asserted-by":"publisher","first-page":"eabg9012","DOI":"10.1126\/sciimmunol.abg9012","volume":"6","author":"P Zwicky","year":"2021","unstructured":"Zwicky, P. et al. IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation. Sci. Immunol. 6, eabg9012 (2021). This report shows that IL-12 can act on interfollicular keratinocytes to reduce psoriasiform inflammation in mice.","journal-title":"Sci. Immunol."},{"key":"1255_CR92","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ncb717","volume":"4","author":"A Schwarz","year":"2002","unstructured":"Schwarz, A. et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat. Cell Biol. 4, 26\u201331 (2002).","journal-title":"Nat. Cell Biol."},{"key":"1255_CR93","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/cvr\/cvy263","volume":"115","author":"J Ye","year":"2019","unstructured":"Ye, J. et al. Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice. Cardiovasc. Res. 115, 1102\u20131113 (2019).","journal-title":"Cardiovasc. Res."},{"key":"1255_CR94","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1600-065X.2008.00705.x","volume":"226","author":"PP Ahern","year":"2008","unstructured":"Ahern, P. P., Izcue, A., Maloy, K. J. & Powrie, F. The interleukin-23 axis in intestinal inflammation. Immunol. Rev. 226, 147\u2013159 (2008).","journal-title":"Immunol. Rev."},{"key":"1255_CR95","doi-asserted-by":"publisher","first-page":"iv16","DOI":"10.1093\/rheumatology\/keab385","volume":"60","author":"Z \u0141ukasik","year":"2021","unstructured":"\u0141ukasik, Z., Gracey, E., Venken, K., Ritchlin, C. & Elewaut, D. Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints. Rheumatology 60, iv16 (2021).","journal-title":"Rheumatology"},{"key":"1255_CR96","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41423-024-01218-x","volume":"21","author":"D Ohara","year":"2024","unstructured":"Ohara, D., Takeuchi, Y. & Hirota, K. Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells. Cell. Mol. Immunol. 21, 1183\u20131200 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"1255_CR97","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","volume":"14","author":"Y Zheng","year":"2008","unstructured":"Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282\u2013289 (2008).","journal-title":"Nat. Med."},{"key":"1255_CR98","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1128\/IAI.05821-11","volume":"80","author":"PJ Dubin","year":"2012","unstructured":"Dubin, P. J. et al. Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 80, 398\u2013409 (2012).","journal-title":"Infect. Immun."},{"key":"1255_CR99","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2022","unstructured":"Mills, K. H. G. IL-17 and IL-17-producing cells in protection versus pathology. Nat. Rev. Immunol. 23, 38\u201354 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1255_CR100","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jaci.2012.05.003","volume":"129","author":"M Akdis","year":"2012","unstructured":"Akdis, M., Palomares, O., Van De Veen, W., Van Splunter, M. & Akdis, C. A. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J. Allergy Clin. Immunol. 129, 1438\u20131449 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1255_CR101","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","volume":"21","author":"D Briukhovetska","year":"2021","unstructured":"Briukhovetska, D. et al. Interleukins in cancer: from biology to therapy. Nat. Rev. Cancer 21, 481\u2013499 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1255_CR102","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature04808","volume":"442","author":"JL Langowski","year":"2006","unstructured":"Langowski, J. L. et al. IL-23 promotes tumour incidence and growth. Nature 442, 461\u2013465 (2006). This is the first report to demonstrate that IL-23 has tumour-promoting properties.","journal-title":"Nature"},{"key":"1255_CR103","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/jcb.24083","volume":"113","author":"S Gangemi","year":"2012","unstructured":"Gangemi, S. et al. Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. J. Cell Biochem. 113, 2122\u20132125 (2012).","journal-title":"J. Cell Biochem."},{"key":"1255_CR104","first-page":"4639","volume":"17","author":"S Sheng","year":"2018","unstructured":"Sheng, S., Zhang, J., Ai, J., Hao, X. & Luan, R. Aberrant expression of IL-23\/IL-23R in patients with breast cancer and its clinical significance. Mol. Med. Rep. 17, 4639\u20134644 (2018).","journal-title":"Mol. Med. Rep."},{"key":"1255_CR105","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/ijc.26130","volume":"130","author":"H Chu","year":"2012","unstructured":"Chu, H. et al. Potentially functional polymorphisms in IL-23 receptor and risk of esophageal cancer in a Chinese population. Int. J. Cancer 130, 1093\u20131097 (2012).","journal-title":"Int. J. Cancer"},{"key":"1255_CR106","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00535-012-0620-1","volume":"48","author":"Y Xu","year":"2013","unstructured":"Xu, Y. et al. IL-23R polymorphisms, HBV infection, and risk of hepatocellular carcinoma in a high-risk Chinese population. J. Gastroenterol. 48, 125\u2013131 (2013).","journal-title":"J. Gastroenterol."},{"key":"1255_CR107","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/carcin\/bgs307","volume":"33","author":"J Zheng","year":"2012","unstructured":"Zheng, J. et al. Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. Carcinogenesis 33, 2409\u20132416 (2012).","journal-title":"Carcinogenesis"},{"key":"1255_CR108","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.molimm.2009.02.025","volume":"46","author":"P Hu","year":"2009","unstructured":"Hu, P. et al. Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. Mol. Immunol. 46, 1654\u20131662 (2009).","journal-title":"Mol. Immunol."},{"key":"1255_CR109","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1158\/0008-5472.CAN-05-4087","volume":"66","author":"S Oniki","year":"2006","unstructured":"Oniki, S. et al. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res. 66, 6395\u20136404 (2006).","journal-title":"Cancer Res."},{"key":"1255_CR110","first-page":"47","volume":"3","author":"BE Shan","year":"2006","unstructured":"Shan, B. E., Hao, J. S., Li, Q. X. & Tagawa, M. Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells. Cell Mol. Immunol. 3, 47\u201352 (2006).","journal-title":"Cell Mol. Immunol."},{"key":"1255_CR111","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1182\/blood-2009-10-248245","volume":"116","author":"C Cocco","year":"2010","unstructured":"Cocco, C. et al. Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. Blood 116, 3887\u20133898 (2010).","journal-title":"Blood"},{"key":"1255_CR112","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.4049\/jimmunol.178.12.7571","volume":"178","author":"T Kaiga","year":"2007","unstructured":"Kaiga, T. et al. Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. J. Immunol. 178, 7571\u20137580 (2007).","journal-title":"J. Immunol."},{"key":"1255_CR113","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature11465","volume":"491","author":"SI Grivennikov","year":"2012","unstructured":"Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth. Nature 491, 254\u2013258 (2012).","journal-title":"Nature"},{"key":"1255_CR114","doi-asserted-by":"publisher","first-page":"8328","DOI":"10.1073\/pnas.1003251107","volume":"107","author":"MWL Teng","year":"2010","unstructured":"Teng, M. W. L. et al. IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis. Proc. Natl Acad. Sci. USA 107, 8328\u20138333 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1255_CR115","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-12-1337","volume":"72","author":"MWL Teng","year":"2012","unstructured":"Teng, M. W. L. et al. Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state. Cancer Res. 72, 3987\u20133996 (2012).","journal-title":"Cancer Res."},{"key":"1255_CR116","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41590-024-01755-7","volume":"25","author":"T Wertheimer","year":"2024","unstructured":"Wertheimer, T. et al. IL-23 stabilizes an effector Treg cell program in the tumor microenvironment. Nat. Immunol. 25, 512\u2013524 (2024).","journal-title":"Nat. Immunol."},{"key":"1255_CR117","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200757119","volume":"119","author":"AE Wight","year":"2022","unstructured":"Wight, A. E. et al. Antibody-mediated blockade of the IL23 receptor destabilizes intratumoral regulatory T cells and enhances immunotherapy. Proc. Natl Acad. Sci. USA 119, e2200757119 (2022). Together with Wertheimer et al. (2022), this study demonstrates that IL-23 stabilizes and promotes Treg cell function in cancer.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1255_CR118","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41577-020-0296-3","volume":"20","author":"LE Lucca","year":"2020","unstructured":"Lucca, L. E. & Dominguez-Villar, M. Modulation of regulatory T cell function and stability by co-inhibitory receptors. Nat. Rev. Immunol. 20, 680\u2013693 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1255_CR119","doi-asserted-by":"publisher","first-page":"1276743","DOI":"10.3389\/fonc.2023.1276743","volume":"13","author":"J Jacobse","year":"2024","unstructured":"Jacobse, J. et al. Distinct roles for interleukin-23 receptor signaling in regulatory T cells in sporadic and inflammation-associated carcinogenesis. Front. Oncol. 13, 1276743 (2024).","journal-title":"Front. Oncol."},{"key":"1255_CR120","doi-asserted-by":"publisher","first-page":"112128","DOI":"10.1016\/j.celrep.2023.112128","volume":"42","author":"J Jacobse","year":"2023","unstructured":"Jacobse, J. et al. Interleukin-23 receptor signaling impairs the stability and function of colonic regulatory T cells. Cell Rep. 42, 112128 (2023).","journal-title":"Cell Rep."},{"key":"1255_CR121","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.immuni.2008.02.019","volume":"28","author":"A Izcue","year":"2008","unstructured":"Izcue, A. et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28, 559\u2013570 (2008).","journal-title":"Immunity"},{"key":"1255_CR122","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","volume":"33","author":"PP Ahern","year":"2010","unstructured":"Ahern, P. P. et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33, 279\u2013288 (2010).","journal-title":"Immunity"},{"key":"1255_CR123","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.celrep.2016.07.054","volume":"16","author":"K Aden","year":"2016","unstructured":"Aden, K. et al. Epithelial IL-23R signaling licenses protective IL-22 responses in intestinal inflammation. Cell Rep. 16, 2208\u20132218 (2016).","journal-title":"Cell Rep."},{"key":"1255_CR124","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485\u2013498 (2009).","journal-title":"Cell"},{"key":"1255_CR125","doi-asserted-by":"publisher","first-page":"13942","DOI":"10.1073\/pnas.1323852111","volume":"111","author":"VFS Shih","year":"2014","unstructured":"Shih, V. F. S. et al. Homeostatic IL-23 receptor signaling limits Th17 response through IL-22-mediated containment of commensal microbiota. Proc. Natl Acad. Sci. USA 111, 13942\u201313947 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1255_CR126","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-025-09120-w","volume":"643","author":"Z White","year":"2025","unstructured":"White, Z. et al. Gut inflammation promotes microbiota-specific CD4 T cell-mediated neuroinflammation. Nature 643, 509\u2013518 (2025).","journal-title":"Nature"},{"key":"1255_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53240-z","volume":"9","author":"AK Kannan","year":"2019","unstructured":"Kannan, A. K. et al. IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases. Sci. Rep. 9, 17675 (2019).","journal-title":"Sci. Rep."},{"key":"1255_CR128","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/jid.2011.139","volume":"131","author":"HJ Bovenschen","year":"2011","unstructured":"Bovenschen, H. J. et al. Foxp3 regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 131, 1853\u20131860 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"1255_CR129","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nri2916","volume":"11","author":"DJ Campbell","year":"2011","unstructured":"Campbell, D. J. & Koch, M. A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11, 119\u2013130 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"1255_CR130","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2024.02.020","volume":"57","author":"TS Kim","year":"2024","unstructured":"Kim, T. S. et al. Epithelial-derived interleukin-23 promotes oral mucosal immunopathology. Immunity 57, 859\u2013875.e11 (2024).","journal-title":"Immunity"},{"key":"1255_CR131","first-page":"1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu, X., Li, J., Fu, M., Zhao, X. & Wang, W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct. Target. Ther. 6, 1\u201333 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1255_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000646","volume":"18","author":"C \u00c1lvarez-Salamero","year":"2020","unstructured":"\u00c1lvarez-Salamero, C. et al. IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics. PLoS Biol. 18, e3000646 (2020).","journal-title":"PLoS Biol."},{"key":"1255_CR133","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-immunol-101320-022432","volume":"40","author":"M Irla","year":"2022","unstructured":"Irla, M. Instructive cues of thymic T cell selection. Annu. Rev. Immunol. 40, 95\u2013119 (2022).","journal-title":"Annu. Rev. Immunol."},{"key":"1255_CR134","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ni1008-1091","volume":"9","author":"TSP Heng","year":"2008","unstructured":"Heng, T. S. P., Painter, M. W. & Immunological Genome Project Consortium The immunological genome project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091\u20131094 (2008).","journal-title":"Nat. Immunol."},{"key":"1255_CR135","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41590-023-01483-4","volume":"24","author":"AJ Brenes","year":"2023","unstructured":"Brenes, A. J., Lamond, A. I. & Cantrell, D. A. The immunological proteome resource. Nat. Immunol. 24, 731 (2023).","journal-title":"Nat. Immunol."},{"key":"1255_CR136","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1126\/sciimmunol.aav1080","volume":"5","author":"D Bauch\u00e9","year":"2020","unstructured":"Bauch\u00e9, D. et al. IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. Sci. Immunol. 5, 1080 (2020).","journal-title":"Sci. Immunol."},{"key":"1255_CR137","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.4049\/jimmunol.172.9.5287","volume":"172","author":"SJ Bensinger","year":"2004","unstructured":"Bensinger, S. J. et al. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172, 5287\u20135296 (2004).","journal-title":"J. Immunol."},{"key":"1255_CR138","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","volume":"111","author":"R Zeiser","year":"2008","unstructured":"Zeiser, R. et al. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood 111, 453\u2013462 (2008).","journal-title":"Blood"},{"key":"1255_CR139","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08155","volume":"460","author":"K Araki","year":"2009","unstructured":"Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"1255_CR140","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jaci.2019.09.025","volume":"145","author":"D Cibrian","year":"2020","unstructured":"Cibrian, D. et al. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation. J. Allergy Clin. Immunol. 145, 199\u2013214.e11 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1255_CR141","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.4049\/jimmunol.169.7.3637","volume":"169","author":"JK Yoo","year":"2002","unstructured":"Yoo, J. K., Cho, J. H., Lee, S. W. & Sung, Y. C. IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase\/Akt signaling pathway. J. Immunol. 169, 3637\u20133643 (2002).","journal-title":"J. Immunol."},{"key":"1255_CR142","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1016\/j.celrep.2019.05.019","volume":"27","author":"Y Cai","year":"2019","unstructured":"Cai, Y. et al. Differential roles of the mTOR\u2013STAT3 signaling in dermal \u03b3\u03b4 T cell effector function in skin inflammation. Cell Rep. 27, 3034\u20133048.e5 (2019).","journal-title":"Cell Rep."},{"key":"1255_CR143","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-023-06816-9","volume":"625","author":"A Cui","year":"2024","unstructured":"Cui, A. et al. Dictionary of immune responses to cytokines at single-cell resolution. Nature 625, 377\u2013384 (2024).","journal-title":"Nature"},{"key":"1255_CR144","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.cell.2021.01.018","volume":"184","author":"CR Glassman","year":"2021","unstructured":"Glassman, C. R. et al. Structural basis for IL-12 and IL-23 shared receptor usage reveals a gateway for shaping actions on T versus NK cells. Cell 184, 983\u2013999.e24 (2021). This report shows an example of a cell-biased partial agonist of IL-12.","journal-title":"Cell"},{"key":"1255_CR145","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2025.04.014","volume":"11","author":"P Berraondo","year":"2025","unstructured":"Berraondo, P. et al. Immunocytokines and cytokine neutralization for cancer immunotherapy. Trends Cancer 11, 790\u2013805 (2025).","journal-title":"Trends Cancer"},{"key":"1255_CR146","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.tibs.2022.09.005","volume":"48","author":"T Aung","year":"2023","unstructured":"Aung, T., Grubbe, W. S., Nusbaum, R. J. & Mendoza, J. L. Recent and future perspectives on engineering interferons and other cytokines as therapeutics. Trends Biochem. Sci. 48, 259\u2013273 (2023).","journal-title":"Trends Biochem. Sci."},{"key":"1255_CR147","doi-asserted-by":"publisher","first-page":"104539","DOI":"10.1016\/j.ebiom.2023.104539","volume":"90","author":"ME Raeber","year":"2023","unstructured":"Raeber, M. E., Sahin, D., Karakus, U. & Boyman, O. A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases. EBioMedicine 90, 104539 (2023).","journal-title":"EBioMedicine"},{"key":"1255_CR148","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli, E., Oukka, M. & Kuchroo, V. K. TH-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345\u2013350 (2007).","journal-title":"Nat. Immunol."},{"key":"1255_CR149","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","volume":"130","author":"O Dienz","year":"2009","unstructured":"Dienz, O. & Rincon, M. The effects of IL-6 on CD4 T cell responses. Clin. Immunol. 130, 27\u201333 (2009).","journal-title":"Clin. Immunol."},{"key":"1255_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich, P. C. et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1\u201320 (2003).","journal-title":"Biochem. J."},{"key":"1255_CR151","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller, J., Chalaris, A., Schmidt-Arras, D. & Rose-John, S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta Mol. Cell Res. 1813, 878\u2013888 (2011).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"1255_CR152","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1089\/jir.2014.0221","volume":"35","author":"IH Chan","year":"2015","unstructured":"Chan, I. H. et al. The potentiation of IFN-\u03b3 and induction of cytotoxic proteins by pegylated IL-10 in human CD8 T cells. J. Interferon Cytokine Res. 35, 948\u2013955 (2015).","journal-title":"J. Interferon Cytokine Res."},{"key":"1255_CR153","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1182\/blood.V98.7.2143","volume":"98","author":"S Fujii","year":"2001","unstructured":"Fujii, S., Shimizu, K., Shimizu, T. & Lotze, M. T. Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ. Blood 98, 2143\u20132151 (2001).","journal-title":"Blood"},{"key":"1255_CR154","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ccr.2011.11.003","volume":"20","author":"JB Mumm","year":"2011","unstructured":"Mumm, J. B. et al. IL-10 elicits IFN\u03b3-dependent tumor immune surveillance. Cancer Cell 20, 781\u2013796 (2011).","journal-title":"Cancer Cell"},{"key":"1255_CR155","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190418","volume":"217","author":"M Saraiva","year":"2020","unstructured":"Saraiva, M., Vieira, P. & O\u2019Garra, A. Biology and therapeutic potential of interleukin-10. J. Exp. Med. 217, e20190418 (2020).","journal-title":"J. Exp. Med."},{"key":"1255_CR156","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O\u2019Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683\u2013765 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"1255_CR157","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/35038103","volume":"407","author":"Q Chen","year":"2000","unstructured":"Chen, Q. et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407, 916\u2013920 (2000).","journal-title":"Nature"},{"key":"1255_CR158","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1158\/0008-5472.CAN-03-2084","volume":"64","author":"M Hisada","year":"2004","unstructured":"Hisada, M. et al. Potent antitumor activity of interleukin-27. Cancer Res. 64, 1152\u20131156 (2004).","journal-title":"Cancer Res."},{"key":"1255_CR159","doi-asserted-by":"publisher","first-page":"1072420","DOI":"10.3389\/fimmu.2022.1072420","volume":"13","author":"Q Jouhault","year":"2022","unstructured":"Jouhault, Q. et al. Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses. Front. Immunol. 13, 1072420 (2022).","journal-title":"Front. Immunol."},{"key":"1255_CR160","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41590-023-01667-y","volume":"24","author":"C-H Lin","year":"2023","unstructured":"Lin, C.-H. et al. Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of TH17 cell immunity. Nat. Immunol. 24, 2108\u20132120 (2023).","journal-title":"Nat. Immunol."},{"key":"1255_CR161","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1600-065X.2007.00565.x","volume":"220","author":"YY Wan","year":"2007","unstructured":"Wan, Y. Y. & Flavell, R. A. \u2018Yin-Yang\u2019 functions of TGF-\u03b2 and Tregs in immune regulation. Immunol. Rev. 220, 199\u2013213 (2007).","journal-title":"Immunol. Rev."},{"key":"1255_CR162","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. Interferon-\u03b3: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163\u2013189 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"1255_CR163","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4049\/jimmunol.156.1.5","volume":"156","author":"IA Ferber","year":"1996","unstructured":"Ferber, I. A. et al. Mice with a disrupted IFN-\u03b3 gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5\u20137 (1996).","journal-title":"J. Immunol."},{"key":"1255_CR164","first-page":"2434","volume":"116","author":"Z Wang","year":"2006","unstructured":"Wang, Z. et al. Role of IFN-\u03b3 in induction of Foxp3 and conversion of CD4+CD25\u2013 T cells to CD4+ Tregs. J. Clin. Invest. 116, 2434\u20132441 (2006).","journal-title":"J. Clin. Invest."},{"key":"1255_CR165","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","volume":"3","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal, B. B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745\u2013756 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"1255_CR166","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1186\/ar569","volume":"4","author":"TW Mak","year":"2002","unstructured":"Mak, T. W. & Yeh, W. C. Signaling for survival and apoptosis in the immune system. Arthritis Res. 4, S243 (2002).","journal-title":"Arthritis Res."},{"key":"1255_CR167","volume":"13","author":"M Zahid","year":"2021","unstructured":"Zahid, M. et al. Tumor necrosis factor alpha blockade and multiple sclerosis: exploring new avenues. Cureus 13, e18847 (2021).","journal-title":"Cureus"},{"key":"1255_CR168","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1016\/j.febslet.2011.04.025","volume":"585","author":"X Chen","year":"2011","unstructured":"Chen, X. & Oppenheim, J. J. Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett. 585, 3611\u20133618 (2011).","journal-title":"FEBS Lett."},{"key":"1255_CR169","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1286-4579(00)01359-9","volume":"3","author":"X Ma","year":"2001","unstructured":"Ma, X. TNF-\u03b1 and IL-12: a balancing act in macrophage functioning. Microbes Infect. 3, 121\u2013129 (2001).","journal-title":"Microbes Infect."},{"key":"1255_CR170","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","volume":"101","author":"AK Mehta","year":"2018","unstructured":"Mehta, A. K., Gracias, D. T. & Croft, M. TNF activity and T cells. Cytokine 101, 14\u201318 (2018).","journal-title":"Cytokine"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-025-01255-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-025-01255-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-025-01255-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:02:23Z","timestamp":1780488143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-025-01255-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":170,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1255"],"URL":"https:\/\/doi.org\/10.1038\/s41577-025-01255-1","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"18 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}